Kamdar Kim P.
SEC-identified person · CIK 1535065 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sera Prognostics, INC. SERA | Director | filed 2021 - 2026 |
| Singular Genomics Systems, Inc. OMIC | Director | filed 2021 - 2025 |
| Neothetics, Inc. NEOT | Director | filed 2014 - 2023 |
| Vyome Holdings, Inc RSLS | Director | filed 2016 - 2020 |
| Bionano Genomics, Inc. BNGO | Officer | filed 2018 - 2018 |
| Tranzyme INC TZYM | Officer | filed 2013 - 2017 |
| Tobira Therapeutics, Inc. TBRA | Officer | filed 2013 - 2016 |
| Syndax Pharmaceuticals Inc SNDX | Director | filed 2016 - 2016 |
| Glaukos Corp GKOS | Officer | filed 2015 - 2015 |
| Atyr Pharma INC LIFE | Officer | filed 2015 - 2015 |
| Durata Therapeutics, Inc. DRTX | Officer | filed 2012 - 2014 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Officer | filed 2014 - 2014 |
| Aldeyra Therapeutics, Inc. ALDX | Officer | filed 2014 - 2014 |
| Cadence Pharmaceuticals INC CADX | Officer | filed 2012 - 2014 |
| Evoke Pharma Inc EVOK | Officer | filed 2013 - 2013 |
| Esperion Therapeutics, Inc. ESPR | Officer | filed 2013 - 2013 |
| Celator Pharmaceuticals Inc CPXX | Officer | filed 2013 - 2013 |
| Achillion Pharmaceuticals INC ACHN | Officer | filed 2012 - 2012 |
| Zogenix, INC. ZGNX | Officer | filed 2012 - 2012 |
| Orexigen Therapeutics, Inc. OREXQ | Officer | filed 2012 - 2012 |
| Clovis Oncology, Inc. CLVS | Officer | filed 2011 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.